tiprankstipranks
AIM ImmunoTech Inc (AIM)
:AIM
US Market

AIM ImmunoTech (AIM) Stock Forecast & Price Target

Compare
884 Followers
See the Price Targets and Ratings of:

AIM Financial Forecast

AIM Earnings Forecast

The previous quarter’s earnings for AIM were -$0.10.
The previous quarter’s earnings for AIM were -$0.10.

AIM Sales Forecast

The previous quarter’s earnings for AIM were $45.00K.
The previous quarter’s earnings for AIM were $45.00K.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Ascendiant
$5$4.5
Buy
3650.00%
Upside
Reiterated
12/08/24
AIM ImmunoTech (AIM) PT Lowered to $4.50 at Ascendiant CapitalAscendiant Capital analyst Edward Woo lowered the price target on AIM ImmunoTech (NYSE: AIM) to $4.50 (from $5.00) while maintaining a Buy rating.
Maxim Group
$2$1
Buy
733.33%
Upside
Reiterated
10/21/24
AIM ImmunoTech price target lowered to $1 from $2 at MaximAIM ImmunoTech price target lowered to $1 from $2 at Maxim
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Ascendiant
$5$4.5
Buy
3650.00%
Upside
Reiterated
12/08/24
AIM ImmunoTech (AIM) PT Lowered to $4.50 at Ascendiant CapitalAscendiant Capital analyst Edward Woo lowered the price target on AIM ImmunoTech (NYSE: AIM) to $4.50 (from $5.00) while maintaining a Buy rating.
Maxim Group
$2$1
Buy
733.33%
Upside
Reiterated
10/21/24
AIM ImmunoTech price target lowered to $1 from $2 at MaximAIM ImmunoTech price target lowered to $1 from $2 at Maxim
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

AIM Analyst Recommendation Trends

Rating
Nov 23
Feb 24
Apr 24
May 24
Oct 24
Strong Buy
4
3
4
4
4
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
4
4
4
In the current month, AIM has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AIM average Analyst price target in the past 3 months is $4.50.
Each month's total comprises the sum of three months' worth of ratings.

AIM Stock Forecast FAQ

What is AIM’s average 12-month price target, according to analysts?
Based on analyst ratings, AIM ImmunoTech Inc’s 12-month average price target is $4.50.
    What is AIM’s upside potential, based on the analysts’ average price target?
    AIM ImmunoTech Inc has 3650.00% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is AIM a Buy, Sell or Hold?
          AIM ImmunoTech Inc has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is AIM ImmunoTech Inc’s price target?
            The average price target for AIM ImmunoTech Inc is $4.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $4.50 ,the lowest forecast is $4.50. The average price target represents 3650.00% Increase from the current price of $0.12.
              What do analysts say about AIM ImmunoTech Inc?
              AIM ImmunoTech Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of AIM?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis